Mild Alzheimer's patients benefit from 40Hz sensory stimulation in national clinical trial
At the Clinical Trials on Alzheimer's Disease conference in Boston Nov. 16, MIT spinoff company Cognito Therapeutics announced the results of its pivotal clinical trial of a noninvasive, device-based approach to Alzheimer's disease (AD) treatment first discovered in The Picower Institute in 2014. The "HOPE" trial included 663 people in two "prespecified" subgroups of volunteers: those with…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.